The effects of medical castration on testes in patients with advanced prostate cancer

Yi-Sheng Huang, Yi Chia Lin, Michael Chin Cheng Lee, Guang Dar Juang, Chung Hsin Yeh, Yi Hong Cheng, Kuang Yu Chou, Hong En Chen, Te Fu Tsai

研究成果: 雜誌貢獻文章同行評審

2 引文 斯高帕斯(Scopus)


Objective: Because of patients' fear of surgery, the psychological symbolism of the male character, and significant encouragement by urologists, the majority of patients with advanced prostate cancer prefer medical castration as a choice of hormonal treatment. We investigated how the preserved testes were affected by medical castration with luteinizing hormone-releasing hormone (LH-RH) agonist and/or antiandrogen therapy. Materials and Methods: Thirty-four consecutive patients with advanced prostate cancer who underwent a bilateral epididymal-sparing orchiectomy were enrolled in this study. Before surgery, 19 of them had received LH-RH agonists and/or antian-drogens, while the other 15 patients had not. Morphological measurements were made immediately after the operation, and a histological examination was performed by a uropathologist with confirmation by urologists. The axial length, weight, and histopathological findings of the testes and prostate-specific antigen (PSA)/tes-tosterone level were compared between the two groups. Histological changes and characteristics were recorded and analyzed. Results: The median axial length and weight of the testes in the 19 patients with prior medical castration were 2.6 (2.0-3.6) cm and 8.0 (6.0-11.5) g, which significantly differed from those with primary surgical castration [4.0 (2.9-5.0) cm and 12.0 (9.0-17.0) g, both p<0.001]. Moreover, profound atrophic and fibrosclerotic changes were noted in the seminiferous tubules in the group with prior medical castration. Specific findings, including basement membrane thickening and interstitial cell hyperplasia, were noted in specimens with prior medical castration. However, the postoperative serum PSA and testosterone levels did not significantly differ between the two groups. Conclusion: Medical castration in patients with advanced prostate cancer indeed caused a significant reduction in the volume and profound pathological change in the testes, which may compromise a patient's expectation of his self-image (symbol of sexual virility).
頁(從 - 到)169-174
期刊Urological Science
出版狀態已發佈 - 12月 2010

ASJC Scopus subject areas

  • 泌尿科學


深入研究「The effects of medical castration on testes in patients with advanced prostate cancer」主題。共同形成了獨特的指紋。